Evaluation of Mycobacterium tuberculosis by conventional methods, GeneXpert and line probe assay in cases of extrapulmonary tuberculosis

Renuka Murhar; Sunita Gajbhiye; Sunanda Shrikhande Zodpey; Shailesh Lichade

doi:10.18203/2320-6012.ijrms20231622

Authors

Renuka Murhar Department of Microbiology, Government Medical College, Nagpur, Maharashtra, India
Sunita Gajbhiye Department of Microbiology, Government Medical College, Nagpur, Maharashtra, India
Sunanda Shrikhande Zodpey Department of Microbiology, Government Medical College, Nagpur, Maharashtra, India
Shailesh Lichade Microbiologist, Intermediate Reference Laboratory State Tuberculosis Demonstration Centre, Nagpur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231622

Keywords:

Extrapulmonary tuberculosis, GeneXpert, LPA, MDR-TB, Mycobacteria, Rifampicin

Abstract

Background: Diagnosis of EPTB is often delayed due to its paucibacillary nature. Diagnostic modalities like conventional methods and molecular methods like GeneXpert are employed for Mycobacteria detection and their results are compared. Line Probe Assay is used for determination of resistance in first line and in second line anti-tubercular drugs.

Methods: In this study 302 extrapulmonary samples from suspected cases of all age groups were included. Samples were first homogenised and decontaminated and then subjected to various diagnostic modalities like microscopy, culture and GeneXpert for Mycobacteria detection. Culture and smear positive isolates were subjected to LPA for determination of drug resistance in first and second-line anti-tubercular drugs.

Results: Out of the 302 extrapulmonary samples, maximum samples were of lymph nodes (19.86%) followed by pus (17.88%). Male to female ratio was 1:3. GeneXpert detected 45.04% positive cases and 5.96% were rifampicin resistant. Positive samples detected by microscopy and culture were 21.19% and 24.17% respectively. When compared to culture, microscopy showed a sensitivity of 86.30% and specificity of 99.56%. GeneXpert reported 100% sensitivity and 72.48% specificity. LPA reported 9.45% isoniazid resistant cases, 4.05% rifampicin resistant cases and 5.40% both isoniazid and rifampicin resistant cases (MDR-TB). Out of the MDR-TB cases, 25% cases were resistant to fluoroquinolones indicating pre-XDR TB.

Conclusions: For Mycobacterium tuberculosis detection in extrapulmonary samples, multiple modalities should be employed so that the bacilli in these samples is not missed and the turn-around time is lowered which is a key to TB control strategy.

Metrics

Metrics Loading ...

References

World Health Organization. Global Tuberculosis Report, 2021. Available at: https://www.who.int/publications/digital/global-tuberculosis-report-2021. Accessed 26 July 2022.

Carrol ED, Clark JE, Cant AJ. Non-pulmonary tuberculosis. Paediatr Respir Rev. 2001;2(2):113-9.

Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005;72(9):1761-8.

World Health Organization. Country Office for India, 2016‎. Index-TB guidelines: guidelines on extra-pulmonary tuberculosis in India. World Health Organization. Country Office for India. Available at: https://apps.who.int/iris/handle/10665/278953. Accessed 26 July 2022

Dusthackeer A, Sekar G, Chidambaram S, Kumar V, Mehta P, Swaminathan S. Drug resistance among extrapulmonary TB patients: six years of experience from a supranational reference laboratory. Indian J Med Res. 2015;142(5):568-74.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199-205.

Arora VK, Chopra KK. Extrapulmonary Tuberculosis. Indian J Tuberc. 2007;54(4):165-7.

Purohit M, Mustafa T. Laboratory diagnosis of extra-pulmonary tuberculosis (EPTB) in resource-constrained setting: state of the art, challenges and the need. JCDR. 2015;9(4):EE01.

Avashia S, Bansal D, Ahuja K, Agrawal V. Comparison of conventional methods with gene xpert mtb/rif assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extra-pulmonary samples. Int J Med Res Rev. 2016;4(2):181-5.

World Health Organization. Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement; 2011. Available at: https://apps.who.int/iris/handle/10665/44602. Accessed 26 July 2022

Guenaoui K, Harir N, Ouardi A, Zeggai S, Sellam F, Bekri F, et al. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases. Ann Transl Med. 2016;4(9).

Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. comparison of LED fluorescent microscopy and the GeneXpert MTB/RIF assay in a district hospital in India. Tuberc Res Treat. 2012;2012:932862.

World Health Organization. Xpert MTB/RIF: World Health Organization Policy Update and Implementation Manual, 2014. Available at: https://www.who.int.xpert. Accessed 23 Dec 2018.

HAIN LifeScience. Genotype MTBDRslVER 2.0 instructions for use. Document IFA-317A-01. Nehren, HAIN LifeScience, 2015.

Rufai SB, Singh S, Singh A, Kumar P, Singh J, Vishal A. Performance of Xpert MTB/RIF on ascitic fluid samples for detection of abdominal tuberculosis. J Lab Physicians. 2017;9(01):047-52.

Procop GW, Church DL, Hall GS, Janda WM. Koneman's Color Atlas and Textbook of Diagnostic Microbiology, 7th ed. Jones & Bartlett Learning, 2020.

Kubica GP, Gross WM, Hawkins JE, Sommers HM, Vestal AL, Wayne LG. Laboratory services for mycobacterial diseases. Am Rev Respir Dis. 1975;112(6):783-7.

Cepheid. Xpert MTB/RIF Assay Test: package insert, 301-1404, Rev. G July 2020. Available at: https://www.cepheid.com/Package%20Insert%20Files/Xpert-MTB-RIF-ENGLISH-Package-Insert-301-1404-Rev-G.pdf. Accessed 23 Dec 2018.

World Health Organization. Line probe assays for drug resistant tuberculosis detection Interpretation and reporting guide for laboratory staff and clinicians. Available at: https://stoptb.org/wg/gli/assets/documents/GLI%20LPA%20selection%20manual%202022.pdf. Accessed 18 November 2022.

Mukherjee S, Biswas D, Begum S, Ghosh P, Pal A, Sarkar S. Role of cartridge based nucleic acid amplification testing in diagnosis of extrapulmonary tuberculosis- experience from a teaching institution in eastern India. Int J Cur Res Rev. 2021;13(8):16-21.

Diriba G, Kebede A, Tola HH, Yenew B, Moga S, Addise D, et al. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia. PLoS ONE. 2020;15(12):e0243493.

Sharma SK, Chaubey J, Singh BK, Sharma R, Mittal A, Sharma A. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India. Inter J Tuber Lung Dis. 2017;21(10):1112-7.

Khan AS, Ali S, Khan MT, Ahmed S, Khattak Y, Irfan M, et al. Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan. Braz J Microbiol. 2018;49:909-13.

Lawn SD, Zulma Al. Diagnosis of extrapulmonary tuberculosis using Xpert MTB/RIF Assay. Expert review of anti-infective therapy. 2012;10(6):631-5.

Fuladi AB, Gupta PP. Challenges in the diagnosis of extrapulmonary tuberculosis: role of gene Xpert Mycobacterium tuberculosis/rifampicin assay. Int J Sci Stud. 2017;5(7):75-9.

Zahoor D, Farhana A, Kanth F, Manzoor M. Evaluation of smear microscopy and GeneXpert for the rapid diagnosis of pulmonary and extrapulmonary tuberculosis in a tertiary care hospital in North India: a descriptive prospective study. Inter J Res Med Sci. 2018;6(5):1756-60.

Habous M, Elimam MA, Kumar R, Deesi ZA. Evaluation of GeneXpert Mycobacterium tuberculosis/rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens. Int J Mycobacteriol. 2019;8(2):132-7.

Kumari M, Khambra P, Panwar K, Yadav I. Rapid diagnosis of tubercular lymphadenopathy by cartridge-based nucleic acid amplification test (CBNAAT) and its correlation with Ziehl-Neelsen staining on fine needle aspiration cytology. Int J Health Sci Res. 2020;10(7):17-21.

Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H, Mandomando I, et al. (2016) Do Xpert MTB/RIF cycle threshold values provide information about patient delays for tuberculosis diagnosis? PLOS ONE 11(9): e0162833.

Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol. 1999;37(11):3578-82.

Bhalla M, Sidiq Z, Sharma PP, Singhal R, Myneedu V, Sarin R. Performance of light-emitting diode fluorescence microscope for diagnosis of tuberculosis. Int Jor Mycobact. 2013;2(3):174-8.

Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF, a new pillar in the diagnosis of extrapulmonary tuberculosis. J Clin Microbiol. 2011;49(7):2540-5.

Moure R, Martin R, Alcaide F. Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis Complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol. 2012;50(2):513-5.

Hillemann D, Rusch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol. 2011;49(4):1202-5.

Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for the rapid diagnosis of tuberculosis and detection of RIF-resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2011;49(12):4138-41.

S V J, Verma AK, Meka M. Diagnostic accuracy of xpert mtb compared to smear microscopy in pulmonary vs extrapulmonary tuberculosis. International J Contemp Med Res. 2019;6(7):G1-G4.

Marlowe EM, Novak Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol. 2011;49(4):1621-3.

Somoskovi A, Deggim V, Ciardo D, Bloemberg GV. Diagnostic implications of inconsistent results obtained with the Xpert MTB/RIF assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance. J Clin Microbiol. 2013;51(9):3127-9.

Desikan P, Kharate A, Panwalkar N, Khurana J, Mirza SB, Chaturvedi A, et al. Frequency of mutations in rifampicin and isoniazid resistant isolates of M. tuberculosis: an analysis from Central India. Germs. 2016;6(4):125-31.

Mchaki BR, Mgaya FX, Kunambi PP, Hang’ombe B, Matee MI, Munyeme M. Comparative performance of line probe assay and GeneXpert in the detection of rifampicin monoresistance in a TB-endemic African country. Antibiotics. 2022;11(11):1489.